Sign up to save your podcasts
Or
Share Vaccine Progress and What’s Next
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Vaccine Progress and What’s Next
Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for FDA approval and widespread distribution.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Goldman Sachs
4.2
918918 ratings
Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for FDA approval and widespread distribution.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Exchanges
View all
Bloomberg Intelligence
403 Listeners
Bloomberg Surveillance
1,167 Listeners
Masters in Business
2,184 Listeners
Odd Lots
2,002 Listeners
Bloomberg Businessweek
423 Listeners
Notes on the Week Ahead
193 Listeners
Capital Allocators – Inside the Institutional Investment Industry
800 Listeners
Wall Street Breakfast
1,037 Listeners
UBS On-Air: Market Moves
188 Listeners
Making Sense
69 Listeners
Thoughts on the Market
1,311 Listeners
At Any Rate
78 Listeners
The Memo by Howard Marks
417 Listeners
Barron's Live
210 Listeners
The Markets
77 Listeners